Evidence map›Paper›PMID 41311836›Full record

ArticleFrontiers in pharmacology2025

Effect of 13 traditional Chinese medicine drug preparations against

Wenfeng Liao, Ke Zhou, Yan Zhang, Yuanqin Huang, Xia Zhang, Yueping Yin, Qian Zhou, Shaochun Chen, Weiyun Li, Wenqi Xu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Wenfeng Liao *Key Laboratory of Cancer Prevention and Therapy, Department of Urologic Oncology, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Ke Zhou *Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, China.
Yan Zhang *Taizhou Center for Disease Control and Prevention, Taizhou, China.
Yuanqin Huang *State Key Laboratory of Green Pesticide, Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, Center for Research and Development of Fine Chemicals, Guizhou University, Guiyang, China.
Xia ZhangDepartment of Biology, Hong Kong Baptist University, Hong Kong SAR, China.
Yueping YinHospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.
Qian ZhouHospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.
Shaochun ChenHospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.
Weiyun LiTianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, China.
Wenqi XuHospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Gonorrhea poses severe health complications, with an estimated 82.4 million new adult infections reported globally in 2020. Currently, ceftriaxone monotherapy remains the first-line treatment in China. However, rising antimicrobial drug resistance necessitates has spurred the urgent need to explore novel therapeutic strategies. This study assessed the antibacterial activity of 13 traditional Chinese medicines (TCMs) against Methods: The minimum inhibitory concentrations (MICs) of 13 TCMs on 280 Results: Coptidis Rhizoma (CR) exhibited the lowest MIC Discussion: This study represents the first report about the antibacterial activity of these 13 TCMs against

Indexed as

antibacterial effectantimicrobial susceptibility testing (AST)gonorrheain vitroNeisseria gonorrhoeaetraditional Chinese medicine (TCM)

Identifiers

PMID41311836
PMCPMC12647010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.